Misonix ends one distribution deal and signs another
This article was originally published in Clinica
Developer of minimally invasive ultrasonic equipment Misonix has called time on its domestic distribution deal for its SonicOne wound debridement system with Medline Industries. According to New York-based Misonix, Medline had been distributing the device on a limited test release basis. With the expiration of the agreement, the two companies have decided that the best distribution model for the product would be for Misonix to use its own distribution network. Medline (Mundelein, Illinois) will cease selling the SonicOne at the end of March 2008. The SonicOne system is designed to remove dead or infected tissue, fibrin and foreign materials from acute and chronic wounds.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.